The goal of this laboratory research is to look for genes that can predict which patients
will achieve a complete disappearance of their colorectal cancer after treatment like
chemotherapy, radiation, or other therapy.
This is an investigational study. Up to 350 patients will take part in this study. All will
be enrolled at MD Anderson.